Navigation Links
Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Directors
Date:9/13/2007

process that resulted in the $45.50 per share cash offer from Teleflex.

Do NOT add risk by voting for the McNeil Trust

There is no need to add uncertainty to the merger closing process by electing new directors, as the McNeil Trust is attempting to do. The McNeil Trust opposed the strategic alternatives process from the beginning and voiced support for the merger only after the transaction was publicly announced. There is a difference between being committed to a transaction and merely agreeing to vote for it. We do not think it is in your best interest to allow nominees of a shareholder who is not committed to completing this merger handle any issues that may arise between the approval of the merger agreement and the closing of the transaction. We believe the McNeil Trust's nominees are not the best option for shareholders. We believe their slate presents added risk to the transaction, and in the unlikely event the merger is not consummated, the Trust's slate offers only a return to the disappointments that existed when the current Board of Directors decided to explore strategic alternatives. We strongly urge you NOT to sign or return any blue proxy cards to the McNeil Trust.

Please vote the WHITE proxy card today

If your shares are held by your brokerage firm or bank, you must provide them with instructions on how to vote on your behalf or they will be unable to vote your shares on certain issues, including the adoption of the merger agreement. Given that time is short, we encourage you to follow the instructions on the enclosed form to vote by telephone or Internet.

If you have any questions or would like assistance in voting your shares of Arrow common stock, please call our proxy solicitor, Morrow & Co., Inc., toll-free at 1-800-662-5200.

Sincerely yours,

Philip B. Fleck

President and Chief Executive Officer

R. James Macaleer

Chairman of the Board of Directors

About Arrow

Arrow develops,
'/>"/>

SOURCE Arrow International, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Creating brain cells from bone marrow
2. Bone marrow transplants for limbs
3. Bone marrow stem cells may help repair cardiac tissues
4. Bones repair themselves with bone marrow cells
5. Bone Marrow Cells Help Heart Attack Patients
6. Bone Marrow Cells Could Yield A New Lease of Life
7. Stem Cells From Bone Marrow Found To Improve Cardiac Functioning After A Heart Attack
8. Umbilical Cord Blood Offers Hope For Patients Who Require Bone Marrow Transplants
9. Mouth wash samples to predict bone marrow transplant results
10. Stents That Release Medication To Check Artery Narrowing
11. Measuring disseminated cancer cells in bone marrow - valuable tool for detecting early breast cancer metastasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...Coach Holly Warlick Teams Up with Legal and Medica...Ever Cancer and Careers Seminar in,Knoxville, KNO...ion of National,Breast Cancer Awareness Month, Can...e joined forces with YWCA Knoxville, The Wellness ...e Holly Warlick, University of Tennessee,women,s b...
(Date:10/10/2008)... The Healthcare Technology Ev... , Exton, PA (PRWEB) Sept...ey Chapters of the national Healthcare Information...forces to bring regional health information techno... conference entitled The Healthcare Technology Evo...
(Date:10/10/2008)...ston, MABoston Medical Center (BMC) has received a...l Institute on Aging (NIA) to fund the Boston Clau...BMC,s Pepper Center is one of only 11 Pepper Cente... Americans Independence Center Program was establi...enator from Florida. During his five decades of pu...
(Date:10/10/2008)...olecular CT adds metabolic information from PET to...gnostic imaging for maximized workflow ...ICH, Germany, Oct. 10 /PRNewswire/ -- Siemens Heal...duces molecular CT, a new concept in,integrated im...d is a,practical solution for today,s shrinking he...
Breaking Medicine News(10 mins):Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2Health News:Boston Medical Center receives $5.8m grant 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 3Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 4
...ad entered a co-development and commercialisation ...he joint development of a drug to treat diabetes. ...ts associated with the Phase-III clinical trials o...PPAR-gamma agonist, for the treatment of type 2 di...
...opical Medicine has published the results of the w...hat the HIV virus has become less pathogenic// due...nsitive to anti-retroviral drugs compared to the s... compared the HIV samples collected in between 198...
...y not require blood transfusion as a treatment pro...form of severe thalassaemia in many Asian// countr...ients, suggests a research letter published online... The authors state that the finding has important ...
...r on the body, says a new study that offers hope f...es at Johns Hopkins University School// of Medicin...ich encodes a protein that is essential for hair f...umans and mice with mutations in the Hairless gene...
Other Medicine News:Health News:Dr Reddy’s Strikes Deal With Rheoscience For Type 2 Diabetes Dru 2
(Date:10/9/2008)...ts Expected in November 2008, BOTHELL, Wash., Oct...Amex: DDD ) announced today the completion of pat...ree pivotal trials to evaluate the safety and,effi...e (ER) ibuprofen for,the over-the-counter (OTC) ma...ts from this pivotal trial in November 2008. Ibupr...
(Date:10/8/2008)...Inform Treatments for Spinal Cord, Other Nerve,Inj...ire/ -- A protein that enables,nerve cells to comm...lling,the developing nervous system. Research into...m among nerve cells may provide a basis for eventu...their nervous system,including spinal cord injury...
(Date:10/8/2008)...Potency of Poly-ICR as Vaccine Adjuvant, SAN DIEG...maceuticals,Corporation (TSX: NVN) today presented...proprietary Toll-like Receptor 3 agonist, Poly IC-...gress 2008 in Lyon, France.,Study results demonstr...eting the Toll-like Receptor 3 (TLR3) pathway. Dat...
(Date:10/7/2008)...y of new device for detecting polyps that can be ...RLANDO, Fla., Oct. 7 /- At the Americ...eeting in Orlando (ACG 2008), renowned,gastroenter...a,multi-institutional clinical study that evaluate...a new device that is designed to improve the abili...
Breaking Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5OneTouch 28R 29 Ping 28TM 29 Glucose Management System Cleared by FDA 23109 1OneTouch 28R 29 Ping 28TM 29 Glucose Management System Cleared by FDA 23109 2OneTouch 28R 29 Ping 28TM 29 Glucose Management System Cleared by FDA 23109 3New technique produces genetically identical stem cells 6347 1New technique produces genetically identical stem cells 6347 2Sign Language Associates and Visual Language Interpreting Combine With GoAmerica to Form Nations Premier Sign Language Interpreting Services Company 23105 1Sign Language Associates and Visual Language Interpreting Combine With GoAmerica to Form Nations Premier Sign Language Interpreting Services Company 23105 2Sign Language Associates and Visual Language Interpreting Combine With GoAmerica to Form Nations Premier Sign Language Interpreting Services Company 23105 3Sign Language Associates and Visual Language Interpreting Combine With GoAmerica to Form Nations Premier Sign Language Interpreting Services Company 23105 4Sign Language Associates and Visual Language Interpreting Combine With GoAmerica to Form Nations Premier Sign Language Interpreting Services Company 23105 5Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case 23101 1Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case 23101 2Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case 23101 3
... 3, 2007 - Xanthus,Pharmaceuticals, Inc today pres... the clinical and pathological signs of chronic,di...he presentation,was made by Stephen J. Karlik, Ph....rsity of Western Ontario, London, Ontario,togethe...n at the,59th American Academy of Neurology Meetin...
...onclinical (IND) In- Vitro,Studies for Promising A...SWIRE) -- Samaritan,Pharmaceuticals Inc. (AMEX:LIV...announce positive results were attained with its,l...spinol (SP-233),with well recognized in-vitro mod...mperfect predictors,of clinical responses, laborat...
Other Medicine Technology:Xanthus Presents Novel Approach for Autoimmune Disease Reversal,with Symadex 2Xanthus Presents Novel Approach for Autoimmune Disease Reversal,with Symadex 3Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 2Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 3
Agarose I (Molecular Biology Grade) - A regular melting temperature agarose for electrophoresis requiring an exceptional level of purity with unequaled performance.
UltraClean Agarose, Molecular Biology Grade, is used for the electrophoretic separation of nucleic acids. It can be used to isolate DNA fragments from 0.2 to 40 kb., Each lot of UltraClean Agarose is
Inquire
High EEO (-mr) (0.23-0.26), suitable for IEP, Gel point (1.5%): 36 1.5 °C Gel strength (1%): > 750 g/cm2.
Medicine Products: